Literature DB >> 24790662

Iron overload in Beta thalassaemia major and intermedia patients.

Amit Kumar Mishra1, Archana Tiwari1.   

Abstract

BACKGROUND: In beta thalassaemia major multiple blood transfusions, ineffective erythropoiesis and increased gastrointestinal iron absorption lead to iron overload in the body. Iron overload impairs the immune system, placing patients at greater risk of infection and illness. Iron overload can be determined by serum ferritin measurement.
OBJECTIVE: The aim of the present study is to assess the serum ferritin levels in multi-transfused Thalassaemia major and Thalassaemia intermedia patients. The study was also done to estimate the present situation of awareness of iron overload in them.
METHODS: Seventy two blood samples from clinically diagnosed thalassaemia major and intermedia patients were collected from different tertiary care hospitals in Bhopal, India for their serum ferritin estimation. Serum ferritin measurement was performed using indirect enzyme linked immune sorbent based serum ferritin assay kit. Data were analyzed to determine association between variables. The association between age, sex, and serum ferritin level were established.
RESULTS: 87.4% of the beta thalassaemia major patients showed very high ferritin levels. The mean serum ferritin level was found to be 2767.52 ng/ml. 44.4% patients had serum ferritin between 1000 to 2500 ng/ml, while 43.05% patients had values above 2500 ng/ml. These levels reflect inadequate chelation and vulnerability to develop iron overload related complications.
CONCLUSION: There is an urgent need to rationalize the chelation therapy and to create awareness about the consequences of iron overload in the patients. The study showed high levels of serum ferritin beta thalassaemia major patients which give an overall bleak view.

Entities:  

Year:  2013        PMID: 24790662      PMCID: PMC3968466     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  24 in total

1.  Pattern of hemoglobinopathies in western Maharashtra.

Authors:  S S Ambekar; M A Phadke; G D Mokashi; M P Bankar; V A Khedkar; V Venkat; D G Basutkar
Journal:  Indian Pediatr       Date:  2001-05       Impact factor: 1.411

Review 2.  Evaluation of iron overload.

Authors:  Peter-D Jensen
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998

3.  Complications of beta-thalassemia major in North America.

Authors:  Melody J Cunningham; Eric A Macklin; Ellis J Neufeld; Alan R Cohen
Journal:  Blood       Date:  2004-02-26       Impact factor: 22.113

Review 4.  Ferritin for the clinician.

Authors:  Mary Ann Knovich; Jonathan A Storey; Lan G Coffman; Suzy V Torti; Frank M Torti
Journal:  Blood Rev       Date:  2008-10-02       Impact factor: 8.250

Review 5.  Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.

Authors:  John B Porter; Bernard A Davis
Journal:  Best Pract Res Clin Haematol       Date:  2002-06       Impact factor: 3.020

Review 6.  Cardiovascular aspect of Beta-thalassaemia.

Authors:  Amar Taksande; Shakuntala Prabhu; Sumitra Venkatesh
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2012-03-01

7.  Deferiprone, efficacy and safety.

Authors:  V P Choudhry; H P Pati; Anita Saxena; A N Malaviya
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

Review 8.  Iron overload following red blood cell transfusion and its impact on disease severity.

Authors:  Caroline P Ozment; Jennifer L Turi
Journal:  Biochim Biophys Acta       Date:  2008-10-18

9.  Iron metabolism in thalassemia and sickle cell disease.

Authors:  Raffaella Mariani; Paola Trombini; Matteo Pozzi; Alberto Piperno
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-10-27       Impact factor: 2.576

Review 10.  MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Authors:  Maria I Argyropoulou; Loukas Astrakas
Journal:  Pediatr Radiol       Date:  2007-08-21
View more
  24 in total

1.  Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.

Authors:  Adisak Tantiworawit; Pimlak Charoenkwan; Sasinee Hantrakool; Worawut Choeyprasert; Chate Sivasomboon; Torpong Sanguansermsri
Journal:  Int J Hematol       Date:  2016-04-06       Impact factor: 2.490

2.  DES-Mutation: System for Exploring Links of Mutations and Diseases.

Authors:  Vasiliki Kordopati; Adil Salhi; Rozaimi Razali; Aleksandar Radovanovic; Faroug Tifratene; Mahmut Uludag; Yu Li; Ameerah Bokhari; Ahdab AlSaieedi; Arwa Bin Raies; Christophe Van Neste; Magbubah Essack; Vladimir B Bajic
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

Review 3.  Genetic Manipulation Strategies for β-Thalassemia: A Review.

Authors:  Nur Atikah Zakaria; Rosnah Bahar; Wan Zaidah Abdullah; Abdul Aziz Mohamed Yusoff; Shaharum Shamsuddin; Ridhwan Abdul Wahab; Muhammad Farid Johan
Journal:  Front Pediatr       Date:  2022-06-15       Impact factor: 3.569

Review 4.  Intestinal calcium transport and its regulation in thalassemia: interaction between calcium and iron metabolism.

Authors:  Kornkamon Lertsuwan; Kannikar Wongdee; Jarinthorn Teerapornpuntakit; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2018-02-26       Impact factor: 2.781

5.  Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.

Authors:  Rasha Abd El-Rahman El-Gamal; Ibrahim Youssef Abdel-Messih; Deena Mohamed Habashy; Shams Eldoha Galal Zaiema; Shaimaa Abdelmalik Pessar
Journal:  Ann Hematol       Date:  2019-12-13       Impact factor: 3.673

6.  The Correlation of Cardiac and Hepatic Hemosiderosis as Measured by T2*MRI Technique with Ferritin Levels and Hemochromatosis Gene Mutations in Iranian Patients with Beta Thalassemia Major.

Authors:  Mohammad Soleiman Soltanpour; Kambiz Davari
Journal:  Oman Med J       Date:  2018-01

7.  Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.

Authors:  Maryam Khavari; Azin Hamidi; Sezaneh Haghpanah; Mohammad Hadi Bagheri; Marzieh Bardestani; Razieh Hantooshzadeh; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2014-07-05       Impact factor: 0.611

8.  The Effects of Nutrition, Exercise, and a Praying Program on Reducing Iron Overload in Patients With Beta-Thalassemia Major: A Randomized Clinical Trial.

Authors:  Zahra Molazem; Roghaye Noormohammadi; Roya Dokouhaki; Maryam Zakerinia; Zahra Bagheri
Journal:  Iran J Pediatr       Date:  2016-06-01       Impact factor: 0.364

9.  A prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health Study.

Authors:  Niwansa Adris; Anita Chai Geik Chua; Matthew William Knuiman; Mark Laurence Divitini; Debbie Trinder; John Kevin Olynyk
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

10.  Echocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq.

Authors:  Ameen Mosa Mohammad
Journal:  BMC Cardiovasc Disord       Date:  2014-12-11       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.